Ipca Laboratories reported an 18% rise in Q1 net profit to Rs 192 crore, driven by robust domestic sales. Revenue increased to Rs 2,093 crore, while exports declined.
New Delhi, Aug 13 (PTI) Ipca Laboratories on Tuesday said its consolidated net profit increased 18 per cent to Rs 192 crore for the first quarter ended June 30, 2024 aided by robust sales in the domestic market.
The drug firm had reported a net profit of Rs 163 crore for the April-June period of last fiscal.
Revenue from operations rose to Rs 2,093 crore for the April-June quarter, as compared to Rs 1,585 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
The drug firm said domestic formulations income rose 12 per cent year-on-year to Rs 873 crore in the first quarter.
Exports income, however, declined 4 per cent year-on-year to Rs 591 crore during the June quarter, the company said.
Shares of Ipca Laboratories on Tuesday closed 1.33 per cent up at Rs 1,400 apiece on the BSE.
Rediff.com » Market News » Ipca Labs Q1 Profit Up 18% to Rs 192 Cr, Domestic Sales Strong
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback